Apple has received Federal Drug Association (FDA) approval for a new Watch feature it says can detect signs of sleep apnea. The tool, available in several Watch models starting this week, uses an ...

Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") today announced that DIGITIVA™, a non-invasive digital health solution for heart failure management, has been listed with ...

New digital health solution for heart failure management puts patients at the center of their care by providing ability for at-home disease monitoring - TOKYO, Sept. 18, 2024 /PRNewswire/ -- Astellas ...

Many people want the same things as they get older: to stay in their own homes, to maintain independence for as long as ...

At the “It’s Glowtime” event where Apple revealed the iPhone 16 lineup, the company pulled off another annual update with the ...

Empagliflozin and dapagliflozin have proven cardiovascular benefits in people with type 2 diabetes at high cardiovascular risk, but their comparative effectiveness is unknown. This study used ...

This press release features multimedia. View the full release here: Using an innovative new Breathing Disturbances metric, ...

New research analyzing the effects of two drugs used to treat type 2 diabetes indicates a consistent lack of cardiovascular and renal benefits in Black populations.

Daily insulin injections can be burdensome to patients but are the cornerstone of type 1 diabetes management and often become necessary over time for type 2 diabetes. Could they soon become a thing of ...

For people with type 1 diabetes, management burden including suboptimal insulin preparations remains a major barrier to ...

People with type 2 diabetes, who display lower levels of diligence, may have a significantly higher risk of developing cardiovascular disease with which diabetes is strongly associated, finds research ...